The past year has produced several important articles in the field of thoracic surgery, spanning many different diseases. Thoracic surgeons continue to investigate methods to perform complex operations and procedures less invasively, with the least possible morbidity to our patients. We also continue to critically evaluate new technology and procedures to ensure that they meet our rigorous standards for oncologic efficacy and for management of benign disease. Importantly, as we continue to evolve, thoracic surgeons have remained focused on optimizing processes of care, both inside and outside the operating room. The purpose of this review is to highlight the major advances in thoracic surgical disease in the year 2016.
KoikeTKitaharaASatoS. Lobectomy versus segmentectomy in radiologically pure solid small-sized non-small cell lung cancer. Ann Thorac Surg2016;101:1354-1360.
2.
AltorkiNKKamelMKNarulaN. Anatomical segmentectomy and wedge resections are associated with comparable outcomes for patients with small cT1N0 non–small cell lung cancer. J Thorac Oncol. 2016;11:1984-1992.
3.
ChangJYSenanSPaulMA. Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials. Lancet Oncol. 2015;16:630-637.
4.
MeyersBFPuriVBroderickSRSamsonPKeoganKCrabtreeTD.Lobectomy versus stereotactic body radiotherapy for stage I non–small cell lung cancer: post hoc analysis dressed up as level-1 evidence?J Thorac Cardiovasc Surg. 2015;150:468-471.
5.
PuriVCrabtreeTDBellJM. Treatment outcomes in stage I lung cancer: a comparison of surgery and stereotactic body radiation therapy. J Thorac Oncol. 2015;10:1776-1784.
6.
RosenJESalazarMCWangZ. Lobectomy versus stereotactic body radiotherapy in healthy patients with stage I lung cancer. J Thorac Cardiovasc Surg. 2016;152:44-54.e9.
7.
OsarogiagbonRUDeckerPABallmanKWigleDAllenMSDarlingGE.Survival implications of variation in the thoroughness of pathologic lymph node examination in American College of Surgeons Oncology Group z0030 (Alliance). Ann Thorac Surg. 2016;102:363-369.
8.
DarlingGEAllenMSDeckerPA. Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1 (less than hilar) non–small cell carcinoma: results of the American College of Surgery Oncology Group Z0030 Trial. J Thorac Cardiovasc Surg. 2011;141:662-670.
9.
RaymondDPSederCWWrightCD. Predictors of major morbidity or mortality after resection for esophageal cancer: a Society of Thoracic Surgeons general thoracic surgery database risk adjustment model. Ann Thorac Surg. 2016;102:207-214.
10.
ShapiroJJanBvan LanschotJHulshofM. Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial. Lancet Oncol. 2016;16:1090-1098.
11.
TapiasLMathisenDWrightC. Outcomes with open and minimally invasive Ivor Lewis esophagectomy after neoadjuvant therapy. Ann Thorac Surg. 2016;101:1097-1103.
12.
SchneiderAMLouieBEWarrenHFFarivarASSchembreDBAyeRW.A matched comparison of per oral endoscopic myotomy to laparoscopic Heller myotomy in the treatment of achalasia. J Gastrointest Surg. 2016;20:1789-1796.
13.
PasquerARenaudFHecF. Is centralization needed for esophageal and gastric cancer patients with low operative risk? A nationwide study. Ann Surg. 2016;264:823-830.
14.
WolfeGIKaminiskiHJAbanIB. Randomized trial of thymectomy in myasthenia gravis. N Engl J Med. 2016;375:511-522.
15.
KangCHHwangYLeeHJParkIKKimYT.Robotic thymectomy in anterior mediastinal mass: propensity score matching study with transsternal thymectomy. Ann Thorac Surg. 2016;102:895-901.
16.
PorteousGHNealJMSleeASchmidtHLowDE.A standardized anesthetic and surgical clinical pathway for esophageal resection. Impact on length of stay and major outcomes. Reg Anesth Pain Med. 2015;40:139-149.
17.
WeijsTJBerkelmansGHNieuwenhuijzenGA. Immediate postoperative oral nutrition following esophagectomy: a multicenter clinical trial. Ann Thorac Surg. 2016;102:1141-1148.
18.
AllenMSBlackmonSHNicoholsFC3rd. Optimal timing of urinary catheter removal after thoracic operations: a randomized controlled study. Ann Thorac Surg. 2016;102:925-930.
19.
StilesBMPoonAGiambroneGP. Incidence and factors associated with hospital readmission after pulmonary lobectomy. Ann Thorac Surg. 2016;101:434-442.
